Kowalski A, Nowak P, Jørgensen K. "Method for the Synthesis of Osimertinib Impurity 40" [P]. European Patent, EP 3873646 A1, 2021-01-19.
发明人郭海燕,罗永刚,徐明华. "A Process for Preparing High-Purity Osimertinib Impurity 40" [P]. 中国发明专利, 专利号 CN 111623094 B, 授权公告日 2022-07-04.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 奥希替尼杂质40 in Pharmaceutical Formulations". Anal. Chem., 2017, 620, (10), 6196-6213.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥希替尼杂质40 as an Impurity". Anal. Methods, 2021, 1553, (11), 4903-4929.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Osimertinib Impurity 40 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 304, (1), 2701-2725.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 奥希替尼杂质40 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2017, 2331, 5775-5791.